E
Eunice L. Kwak
Researcher at Harvard University
Publications - 148
Citations - 24080
Eunice L. Kwak is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer & FOLFIRINOX. The author has an hindex of 49, co-authored 146 publications receiving 21705 citations.
Papers
More filters
Proceedings ArticleDOI
Abstract LB-202: Responses to sequential sapacitabine and seliciclib in patients with BRCA-deficient solid tumors.
Geoffrey I. Shapiro,John Hilton,James M. Cleary,Sara M. Tolaney,Leena Ghandi,Eunice L. Kwak,Jeffrey W. Clark,Andrew Wolanski,Tracy Bell,John T. Schulz,Sheelagh Frame,Chiara Saladino,Morag Hogben,Scott J. Rodig,Judy H. Chiao,David Blake +15 more
TL;DR: Sequential sapacitabine and seliciclib is safe with preliminary antitumor activity and BRCA mutation carrier status may be a potential biomarker for response across multiple tumor types.
Journal ArticleDOI
Effect of molecular genotyping to predict outcomes in patients with metastatic pancreatic cancer.
Jason E. Faris,Darrell R. Borger,Carlos Fernandez-del Castillo,Jeffrey W. Clark,Lawrence S. Blaszkowsky,Andrew X. Zhu,Jill N. Allen,Janet E. Murphy,Cristina R. Ferrone,Lipika Goyal,Nabeel Bardeesy,Gabriel Dan Duda,Hui Zheng,David T. Ting,Eunice L. Kwak,Keith D. Lillemoe,Jennifer Y. Wo,A. John Iafrate,David P. Ryan,Theodore S. Hong +19 more
TL;DR: A molecular genotyping test, SNaPshot, is utilized to detect tumor-specific mutations in patients with MPC that received treatment at the MGH Cancer Center to evaluate correlations between genotype, demographics, clinical characteristics, and outcomes.
Journal ArticleDOI
A Single Arm Phase 2 Study of Individualized Proton-Based Stereotactic Body Radiation Therapy (P-SBRT) of Liver Metastases
Theodore S. Hong,Jennifer Y. Wo,Erin McDonnell,Beow Y. Yeap,Lorraine C. Drapek,John A. Wolfgang,Lawrence S. Blaszkowsky,Eunice L. Kwak,Jeffrey W. Clark,Shyam K. Tanguturi,Lipika Goyal,Jill N. Allen,David P. Ryan,Ronald S. Arellano,John T. Mullen,Harvey J. Mamon,Thomas F. DeLaney,Andrew X. Zhu +17 more
Journal ArticleDOI
Long-term Outcomes of Neoadjuvant Chemotherapy (NC) before Chemoradiation (CRT) for Locally Advanced Pancreatic Cancer (LAPC)
Nils D. Arvold,David P. Ryan,Andrzej Niemierko,Lawrence S. Blaszkowsky,Eunice L. Kwak,Jennifer Y. Wo,Jill N. Allen,Raymond C. Wadlow,C. Fernandez-del Castillo,Theodore S. Hong +9 more
Journal ArticleDOI
Evofosfamide combined with gemcitabine/nab-paclitaxel in patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma (PAC): Results of a phase I trial.
Mitesh J. Borad,Eunice L. Kwak,Andrea Wang-Gillam,Ayman Ibrahim,Julie Aldridge,Anthony J. Olszanski +5 more
TL;DR: The once-weekly treatment with Gemcitabine + nab-paclitaxel with Evofosfamide for advanced PAC patients with high blood pressure and high creatinineolerance is shown to be a safe and effective combination.